Medical Devices North America

North America Rapid Antigen Tests Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

North America Rapid Antigen Tests Market Industry Trends and Forecast to 2034: Segmented by (Disease, User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

North America · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $4.37 Bn Placeholder estimate
Estimate 2025 $4.46 Bn 46.7% of the global market
Projected 2034 $5.28 Bn 18.5% Adds $822.8 Mn over 9 forecast years
CAGR 2025–2034 1.9% Faster than 0% of 173 Medical Devices markets here
Key players 5
  • North America is 46.68% of the global market.
  • Among regions, the largest is North America (this report) at $4.46 Bn.
  • Fastest growing: Africa at 4.8% a year.
  • North America ranks 1st of 6 by size among regions.

Market size projection

North America

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$822.8 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Rapid Antigen Tests Market market size by year, North America
YearMarket sizeChange that yearSince 2025
2024 (estimate) $4.37 Bn — —
2025 (base) $4.46 Bn +$83.1 Mn —
2026 (forecast) $4.54 Bn +$84.7 Mn +1.9%
2027 (forecast) $4.63 Bn +$86.3 Mn +3.8%
2028 (forecast) $4.72 Bn +$87.9 Mn +5.8%
2029 (forecast) $4.81 Bn +$89.6 Mn +7.8%
2030 (forecast) $4.90 Bn +$91.3 Mn +9.9%
2031 (forecast) $4.99 Bn +$93.0 Mn +12%
2032 (forecast) $5.09 Bn +$94.8 Mn +14.1%
2033 (forecast) $5.18 Bn +$96.6 Mn +16.3%
2034 (forecast) $5.28 Bn +$98.5 Mn +18.5%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

North America Rapid Antigen Tests Market Analysis at a glance
Market size, 2025$4.46 Bn placeholder estimate
Forecast, 2034$5.28 Bn placeholder estimate
Growth (CAGR), 2025–20341.9% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsDisease and user (see all)
Key playersAbbott Laboratories, Quidel Corporation, Roche Diagnostics, SD Biosensor, BD (Becton, Dickinson) (see all)
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The North America Rapid Antigen Tests Market Analysis Executive Summary

Rapid antigen tests detect proteins from viruses or bacteria in minutes, used for flu, COVID-19, strep throat and more.

Key segments of the rapid Antigen Tests market include disease (Influenza, COVID-19 and Strep A) and user (Professional and Self-Test).

Bar chart: North America Rapid Antigen Tests market size, 2024–2034, placeholder estimates. $4.37 Bn in 2024, $4.46 Bn in 2025 and $5.28 Bn in 2034, 1.9% CAGR.
North America Rapid Antigen Tests market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

North America Rapid Antigen Tests Market Dynamics

Market Growth Drivers

Demand for earlier and faster diagnosis, growth of testing outside hospitals, new molecular technologies and the shift to preventive care are driving the rapid Antigen Tests market.

Opportunity

Home testing, connected devices that send results to doctors and multiplex tests that check many conditions at once give the rapid Antigen Tests market room to grow, especially in emerging markets.

Market Restraints

Pricing pressure, uneven reimbursement for new tests, regulatory approval times and the need for skilled lab staff hold back the rapid Antigen Tests market.

Competitive Landscape for Rapid Antigen Tests Market in North America

The rapid Antigen Tests market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Rapid Antigen Tests Market in North America

Rapid Antigen Tests in North America: rules and payment

In the countries we cover here, medical devices are regulated by Health Canada (Canada)⁠[1] and FDA (US)⁠[2]. How care is paid for in these countries: provincial health insurance (Canada)⁠[3] and Medicare and Medicaid (US)⁠[4].

[1] Health Canada. Checked 14 Nov 2026.

[2] US Food and Drug Administration. Checked 14 Nov 2026.

[3] Health Canada. Checked 14 Nov 2026.

[4] Centers for Medicare & Medicaid Services. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how rapid Antigen Tests products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in North America.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Rapid Antigen Tests right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Rapid Antigen Tests in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Rapid Antigen Tests market in North America?
Placeholder estimate: about $4.46 Bn in 2025, rising to about $5.28 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Rapid Antigen Tests market in North America growing?
Placeholder estimate: about 1.9% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Rapid Antigen Tests market report cover?
The report splits the market by disease (Influenza, COVID-19, Strep A, RSV and more) and user (Professional, Self-Test).
Who are the key players in the Rapid Antigen Tests market?
Key players include Abbott Laboratories, Quidel Corporation, Roche Diagnostics, SD Biosensor and BD (Becton, Dickinson).
What is driving the Rapid Antigen Tests market?
Demand for earlier and faster diagnosis, growth of testing outside hospitals, new molecular technologies and the shift to preventive care are driving the rapid Antigen Tests market.
How much research is published on Rapid Antigen Tests?
PubMed lists 571 papers on Rapid Antigen Tests added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Medical Devices reports in North America

See all

Related on diagnostics and lab testing and infectious diseases

See the topic